Daniel Canelas
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Daniel Canelas has a total of 43 co-authors. Here are the top co-authors by number of shared publications:
- Abel García Abejas
Universidade da Beira Interior Faculdade de Ciencias da Saude
4 shared publications - Fábio Leite Costa
Faculdade de Ciências da Saúde, Universidade da Beira Interior, Covilhã, Portugal
4 shared publications - Hugo Ribeiro
Faculty of Medicine, University of Porto, 4200-319 Porto, Portugal
3 shared publications - Maria Ana Sobral
Unidade de Hospitalização Domiciliária, Hospital Cuf Tejo, Lisboa, Portugal. Centro de Saúde CUF Campo de Ourique, Campo de Ourique, Portugal
3 shared publications - Àngels Salvador Verges
Vall d’Hebron Research Institute (VHIR), Spain
3 shared publications - Adrià Serra Trullás
Servicio de Cirugía Ortopédica y Traumatología, Hospital Clinic, Barcelona, Spain
2 shared publications
Latest Publications
- Open Access
- 11 December 2025
- Published by MDPI AG in Journal of Dementia and Alzheimer's Disease
- Vol. 2 (4) , 47
IPOS-Dem Scale in the Assessment of Patients with Dementia in Palliative Care—Potential for Adaptation: A Systematic Review
Background: Dementia is a chronic, multifactorial syndrome with a high incidence and prevalence worldwide. The clinical assessment of these patients is challenging, imposing several barriers related to the system, the healthcare professional and the patient. While numerous assessment tools exist for dementia, few are specifically validated or widely used in palliative care. This study evaluates the relevance of using the Integrated Palliative Outcome Scale for Dementia (IPOS-Dem) in Portugal. The primary objective is to synthesize evidence on the implementation and clinical performance of IPOS-Dem in people with dementia receiving palliative care—including feasibility, acceptability, validity, reliability, and clinical applicability—while the secondary objective is to assess the instrument’s relevance and potential for cultural/linguistic adaptation to context. Methods: A systematic review of the literature was carried out, with research in evidence-based medicine databases on the use of the Integrated Palliative Outcome Scale for Dementia (IPOS-Dem) in palliative care, using the terms “dementia”, “alzheimer”, “lewy body”, “cognitive impair”, “outcome”, “IPOS-Dem”, “patient outcome assessment”, “outcome assessment”, “scale”, “palliative care”, and “palliative outcome scale”. Results: The IPOS-Dem was considered to be a useful tool for monitoring patients with dementia while receiving palliative care, allowing for a comprehensive and systematic evaluation of symptoms, as well as involving family members in the care process. It facilitates the identification of previously unknown symptoms and issues, particularly emotional and social concerns. Its use led to an improvement in symptom control and greater family involvement in care. The reduction in missing response rates and the time required to complete the scale with repeated use indicated good adaptation to the scale’s implementation. Difficulties were reported in assessing patients with communication impairments. Some staff also highlighted the need for training in using the scale. The Swiss Easy-Read IPOS-Dem showed significant variation in scores between evaluators, which raises concerns about the reliability and consistency of the scale, indicating that the tool requires further validation. Digital models, although they may present some inconveniences, were suggested as a potential improvement in acceptability. Conclusions: Our review suggests that IPOS-Dem provides initial evidence of feasibility, acceptability, and potential clinical usefulness in dementia palliative care, making its implementation beneficial for the Portuguese population. Translation and adaptation to the Portuguese population and culture will be necessary, but the scale is promising, and we recommend its national use.
- 11 December 2025
- Published by MDPI AG in Journal of Dementia and Alzheimer's Disease
- Vol. 2 (4) , 47
Open AccessIPOS-Dem Scale in the Assessment of Patients with Dementia in Palliative Care—Potential for Adaptation: A Systematic Review
Background: Dementia is a chronic, multifactorial syndrome with a high incidence and prevalence worldwide. The clinical assessment of these patients is challenging, imposing several barriers related to the system, the healthcare professional and the patient. While numerous assessment tools exist for dementia, few are specifically validated or widely used in palliative care. This study evaluates the relevance of using the Integrated Palliative Outcome Scale for Dementia (IPOS-Dem) in Portugal. The primary objective is to synthesize evidence on the implementation and clinical performance of IPOS-Dem in people with dementia receiving palliative care—including feasibility, acceptability, validity, reliability, and clinical applicability—while the secondary objective is to assess the instrument’s relevance and potential for cultural/linguistic adaptation to context. Methods: A systematic review of the literature was carried out, with research in evidence-based medicine databases on the use of the Integrated Palliative Outcome Scale for Dementia (IPOS-Dem) in palliative care, using the terms “dementia”, “alzheimer”, “lewy body”, “cognitive impair”, “outcome”, “IPOS-Dem”, “patient outcome assessment”, “outcome assessment”, “scale”, “palliative care”, and “palliative outcome scale”. Results: The IPOS-Dem was considered to be a useful tool for monitoring patients with dementia while receiving palliative care, allowing for a comprehensive and systematic evaluation of symptoms, as well as involving family members in the care process. It facilitates the identification of previously unknown symptoms and issues, particularly emotional and social concerns. Its use led to an improvement in symptom control and greater family involvement in care. The reduction in missing response rates and the time required to complete the scale with repeated use indicated good adaptation to the scale’s implementation. Difficulties were reported in assessing patients with communication impairments. Some staff also highlighted the need for training in using the scale. The Swiss Easy-Read IPOS-Dem showed significant variation in scores between evaluators, which raises concerns about the reliability and consistency of the scale, indicating that the tool requires further validation. Digital models, although they may present some inconveniences, were suggested as a potential improvement in acceptability. Conclusions: Our review suggests that IPOS-Dem provides initial evidence of feasibility, acceptability, and potential clinical usefulness in dementia palliative care, making its implementation beneficial for the Portuguese population. Translation and adaptation to the Portuguese population and culture will be necessary, but the scale is promising, and we recommend its national use.
- Open Access
- 8 October 2025
- Published by Springer Nature in Research Square
From the community to palliative care units: what is the added value in the transition of care?
This study characterizes the patient population receiving care within a specific Palliative Care Unit (PCU) in Portugal and analyzes the transition between community, inpatient units and specialized palliative care settings related to clinical and patient outcomes.Utilizing a retrospective cohort and descriptive design, data were collected from clinical records of patients admitted to the PCU during 2024.The study involved 206 patients with a mean age of 66.2 years. The leading referral source was hospital settings. Oncological disease was the predominant underlying diagnosis (58.3%), followed by organ failure (22.3%). The primary reason for referral was clinical worsening (53.4%).Key findings reveal that patients referred from the community had a more diverse case mix, including organ failure. There were significant associations between social support, understanding, and the prognosis of cancer patients.These insights highlight the importance of tailored approaches to palliative care interventions, considering the patient's referral pathway and underlying diagnoses. Future research should evaluate patient-reported outcomes and explore causal relationships between medication management, psychosocial support, and overall quality of life.
- 8 October 2025
- Published by Springer Nature in Research Square
Open AccessFrom the community to palliative care units: what is the added value in the transition of care?
This study characterizes the patient population receiving care within a specific Palliative Care Unit (PCU) in Portugal and analyzes the transition between community, inpatient units and specialized palliative care settings related to clinical and patient outcomes.Utilizing a retrospective cohort and descriptive design, data were collected from clinical records of patients admitted to the PCU during 2024.The study involved 206 patients with a mean age of 66.2 years. The leading referral source was hospital settings. Oncological disease was the predominant underlying diagnosis (58.3%), followed by organ failure (22.3%). The primary reason for referral was clinical worsening (53.4%).Key findings reveal that patients referred from the community had a more diverse case mix, including organ failure. There were significant associations between social support, understanding, and the prognosis of cancer patients.These insights highlight the importance of tailored approaches to palliative care interventions, considering the patient's referral pathway and underlying diagnoses. Future research should evaluate patient-reported outcomes and explore causal relationships between medication management, psychosocial support, and overall quality of life.
- Open Access
- 1 August 2025
- Published by MDPI AG in Antibiotics
- Vol. 14 (8) , 782
Benefits and Harms of Antibiotic Use in End-of-Life Patients: Retrospective Study in Palliative Care
Context: Many patients at the end of life receive antibiotics to alleviate symptoms and improve quality of life; however, clear guidelines supporting decision making about the use of antibiotics are still lacking. Objectives: This study aimed to evaluate the benefits and harms of antibiotic use among patients under a palliative care community support team in Portugal. Methods: An observational, cross-sectional, retrospective study was conducted on 249 patients who died over a two-year period, having been followed for at least 30 days prior to their death. Data included patient demographics, clinical diagnoses, antibiotic prescriptions, and symptomatic outcomes. The effects of commonly prescribed antibiotics—amoxicillin + clavulanic acid, cefixime, ciprofloxacin, and levofloxacin—were compared using statistical analyses to assess survival, symptom intensity, and functional scales. Results: Adverse events, primarily infections and secretions, occurred in 57.8% of cases, with 33.7% receiving antibiotics. No significant difference in survival was observed across the antibiotic groups (p = 0.990). Symptom intensity significantly reduced after 72 h of treatment (p < 0.05), with ciprofloxacin demonstrating the greatest symptom control. The Palliative Outcome Scale decreased uniformly, with higher scores associated with amoxicillin + clavulanic acid (p = 0.004). The Palliative Performance Scale declined post-treatment, with significant changes noted for cefixime and ciprofloxacin (p < 0.05). Conclusions: Antibiotics may improve symptom control and quality of life in the end-of-life stage. While second-line antibiotics may offer additional benefits, the heterogeneity of the sample and limited adverse effect data underscore the need for further research to guide appropriate prescription practices in palliative care.
- 1 August 2025
- Published by MDPI AG in Antibiotics
- Vol. 14 (8) , 782
Open AccessBenefits and Harms of Antibiotic Use in End-of-Life Patients: Retrospective Study in Palliative Care
Context: Many patients at the end of life receive antibiotics to alleviate symptoms and improve quality of life; however, clear guidelines supporting decision making about the use of antibiotics are still lacking. Objectives: This study aimed to evaluate the benefits and harms of antibiotic use among patients under a palliative care community support team in Portugal. Methods: An observational, cross-sectional, retrospective study was conducted on 249 patients who died over a two-year period, having been followed for at least 30 days prior to their death. Data included patient demographics, clinical diagnoses, antibiotic prescriptions, and symptomatic outcomes. The effects of commonly prescribed antibiotics—amoxicillin + clavulanic acid, cefixime, ciprofloxacin, and levofloxacin—were compared using statistical analyses to assess survival, symptom intensity, and functional scales. Results: Adverse events, primarily infections and secretions, occurred in 57.8% of cases, with 33.7% receiving antibiotics. No significant difference in survival was observed across the antibiotic groups (p = 0.990). Symptom intensity significantly reduced after 72 h of treatment (p < 0.05), with ciprofloxacin demonstrating the greatest symptom control. The Palliative Outcome Scale decreased uniformly, with higher scores associated with amoxicillin + clavulanic acid (p = 0.004). The Palliative Performance Scale declined post-treatment, with significant changes noted for cefixime and ciprofloxacin (p < 0.05). Conclusions: Antibiotics may improve symptom control and quality of life in the end-of-life stage. While second-line antibiotics may offer additional benefits, the heterogeneity of the sample and limited adverse effect data underscore the need for further research to guide appropriate prescription practices in palliative care.
- Open Access
- 28 July 2025
- Published by BMJ in BMJ Open Quality
- Vol. 14 (3) , e003376
Understanding physicians' views on patient-reported outcome measures (PROMs) in lung cancer care: a qualitative approach
Background: Patient-reported outcome measures (PROMs) are increasingly recognised as valuable tools for personalising care pathways and improving the quality of life for patients with lung cancer. PROMs capture patients’ perceptions of symptoms and functional status, while patient-reported experience measures focus on how patients perceive the care process, communication, empathy and accessibility. However, integrating PROMs into clinical practice remains challenging. This study explores physicians’ perceptions of PROMs in lung cancer care, their impact and the barriers and facilitators to their implementation. Objectives: This study seeks to understand physicians’ perspectives on the role of PROMs in enhancing the quality of life, dignity and autonomy of patients with lung cancer and to identify key barriers and facilitators to their integration into clinical practice. Methods: 16 semistructured interviews were conducted with physicians treating patients with lung cancer. A hybrid thematic analysis was used to identify key themes and patterns in the data. Results: Three main themes emerged: (1) patient-related factors, such as health literacy and emotional distress; (2) the influence of social and family environments and (3) the role of PROMs in clinical decision-making. While PROMs were valued for their potential to improve care, barriers like digital literacy and socioeconomic factors hindered their application. Specifically, the study found that while physicians valued the potential of PROMs to improve patient care, several barriers, including patients’ digital literacy and socioeconomic factors, hindered their practical application. Conclusions: PROMs offer a pathway to enhance patient-centred care in lung cancer treatment. However, their successful integration requires addressing barriers such as health literacy, digital access and multidisciplinary collaboration. Future research should focus on strategies for effective PROM integration into clinical workflows and investigate methods for effectively integrating PROMs into routine clinical workflows.
- 28 July 2025
- Published by BMJ in BMJ Open Quality
- Vol. 14 (3) , e003376
Open AccessUnderstanding physicians' views on patient-reported outcome measures (PROMs) in lung cancer care: a qualitative approach
Background: Patient-reported outcome measures (PROMs) are increasingly recognised as valuable tools for personalising care pathways and improving the quality of life for patients with lung cancer. PROMs capture patients’ perceptions of symptoms and functional status, while patient-reported experience measures focus on how patients perceive the care process, communication, empathy and accessibility. However, integrating PROMs into clinical practice remains challenging. This study explores physicians’ perceptions of PROMs in lung cancer care, their impact and the barriers and facilitators to their implementation. Objectives: This study seeks to understand physicians’ perspectives on the role of PROMs in enhancing the quality of life, dignity and autonomy of patients with lung cancer and to identify key barriers and facilitators to their integration into clinical practice. Methods: 16 semistructured interviews were conducted with physicians treating patients with lung cancer. A hybrid thematic analysis was used to identify key themes and patterns in the data. Results: Three main themes emerged: (1) patient-related factors, such as health literacy and emotional distress; (2) the influence of social and family environments and (3) the role of PROMs in clinical decision-making. While PROMs were valued for their potential to improve care, barriers like digital literacy and socioeconomic factors hindered their application. Specifically, the study found that while physicians valued the potential of PROMs to improve patient care, several barriers, including patients’ digital literacy and socioeconomic factors, hindered their practical application. Conclusions: PROMs offer a pathway to enhance patient-centred care in lung cancer treatment. However, their successful integration requires addressing barriers such as health literacy, digital access and multidisciplinary collaboration. Future research should focus on strategies for effective PROM integration into clinical workflows and investigate methods for effectively integrating PROMs into routine clinical workflows.
- Open Access
- 23 November 2023
- Published by JMIR Publications Inc. in JMIR Preprints
Perspectives of physicians treating lung cancer patients on the clinical use of outcomes: A qualitative study (Preprint)
BACKGROUND Using patient-reported outcome measures (PROMs) in scales can help personalize patient care pathways, including the frequency and type of clinical review. This study aims to elucidate the perceptions of physicians treating lung cancer patients regarding outcomes through questionnaires and establish relationships related to the patient, their social and family environment, with diagnosis and treatment. We also set out to identify barriers and facilitators to using these outcome measures. OBJECTIVE Our primary objective was to gain insight into physicians' perceptions of outcomes in treating lung cancer patients, their impact on quality of life, and how their dignity is respected. We explore the results described by doctors of the different needs and experiences of people with lung cancer in other dimensions. We also decided while identifying barriers and facilitators to using these outcome measures. METHODS We conducted 16 semi-structured interviews via videoconferencing with health professionals, focusing on their expert opinions on the perceived importance of their patients' outcomes and the most relevant risk variables. To this end, we conducted a qualitative thematic analysis was performed. RESULTS The primary groups identified in the interview analysis were patient-related, social, and family environment, and diagnosis and treatment. Some found a difference between physicians' perception of outcomes and the experiences of patients and caregivers. CONCLUSIONS PROMs should be implemented in daily clinical care routines. Digitalization of PROMs can facilitate their use. Barriers and facilitators are viewed as methodological divisions, influenced by factors like health literacy, digital literacy, and socioeconomic level. The relevance of PROMs lies in the feedback and subsequent management of outcomes with patients. It is a unique tool to improve the patient's spiritual needs, quality of life, and dignity. Doctors are focused on clinical Outcomes. CLINICALTRIAL
- 23 November 2023
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessPerspectives of physicians treating lung cancer patients on the clinical use of outcomes: A qualitative study (Preprint)
BACKGROUND Using patient-reported outcome measures (PROMs) in scales can help personalize patient care pathways, including the frequency and type of clinical review. This study aims to elucidate the perceptions of physicians treating lung cancer patients regarding outcomes through questionnaires and establish relationships related to the patient, their social and family environment, with diagnosis and treatment. We also set out to identify barriers and facilitators to using these outcome measures. OBJECTIVE Our primary objective was to gain insight into physicians' perceptions of outcomes in treating lung cancer patients, their impact on quality of life, and how their dignity is respected. We explore the results described by doctors of the different needs and experiences of people with lung cancer in other dimensions. We also decided while identifying barriers and facilitators to using these outcome measures. METHODS We conducted 16 semi-structured interviews via videoconferencing with health professionals, focusing on their expert opinions on the perceived importance of their patients' outcomes and the most relevant risk variables. To this end, we conducted a qualitative thematic analysis was performed. RESULTS The primary groups identified in the interview analysis were patient-related, social, and family environment, and diagnosis and treatment. Some found a difference between physicians' perception of outcomes and the experiences of patients and caregivers. CONCLUSIONS PROMs should be implemented in daily clinical care routines. Digitalization of PROMs can facilitate their use. Barriers and facilitators are viewed as methodological divisions, influenced by factors like health literacy, digital literacy, and socioeconomic level. The relevance of PROMs lies in the feedback and subsequent management of outcomes with patients. It is a unique tool to improve the patient's spiritual needs, quality of life, and dignity. Doctors are focused on clinical Outcomes. CLINICALTRIAL
- Open Access
- 3 May 2023
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 25, e46259
Improving the Understanding and Managing of the Quality of Life of Patients With Lung Cancer With Electronic Patient-Reported Outcome Measures: Scoping Review
Background: Electronic patient-reported outcome measures (ePROMs) are essential to clinical practice and research. The growth of eHealth technologies has provided unprecedented opportunities to collect information systematically through ePROMs. Although they are widely used in scientific research, more evidence is needed to determine their use and implementation in daily clinical practice. For example, when diagnosed, patients with lung cancer are at an advanced stage of the disease. This entails tremendous burden because of high mortality and losses in the different dimensions of the human being. In this case, monitoring symptoms and other outcomes help improve the patient’s quality of life. Objective: ePROMs offered unprecedented opportunities to collect information systematically. Our goal was to demonstrate that ePROMs are more useful in controlling patient symptoms, lung cancer, and overall survival than their alternatives, such as nonelectronic PROMs. Methods: This exploratory review considered articles published between 2017 and 2022 identified through searches of PubMed, Scopus, Cochrane, CINAHL, and PsycINFO. We found 5097 articles; after removing the duplicates, we reduced them to 3315. After reading the summary, we were left with 56. Finally, after applying the exclusion criteria, we reviewed 12. The 5-step framework by Arksey and O’Malley was used to refine the initial search results with the following research questions: Do ePROMs help physician-patient communication? To what extent do they improve decision-making? Are institutions and their digitization policies barriers to or facilitators of this process? and What else is needed for routine implementation? Results: This review included 12 articles. We found that ePROMs are an integrative and facilitative communication tool, highlighting their importance in the relationship between palliative care and medical oncology. ePROMs help assess patient symptoms and functionality more accurately and facilitate clinical decision-making. In addition, it allows for more precise predictions of overall patient survival and the adverse effects of their treatments. The main institutional obstacles are the initial investment, which can be costly, and the data protection policy. However, enablers included better funding through the development of telemedicine, support from institutional leaders to overcome resistance to change, and transparent policies to ensure the safe and secure use of ePROMs. Conclusions: Routine collection of remote ePROMs is an effective and valuable strategy for providing real-time clinical feedback. In addition, it provides satisfaction to patients and professionals. Optimizing ePROMs in patients with lung cancer leads to a more accurate view of health outcomes and ensures quality patient follow-up. It also allows us to stratify patients based on their morbidity, creating specific follow-ups for their needs. However, data privacy and security are concerns when using ePROMs to ensure compliance with local entities. At least four barriers were identified: cost, complex programming within health systems, safety, and social and health literacy.
- 3 May 2023
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 25, e46259
Open AccessImproving the Understanding and Managing of the Quality of Life of Patients With Lung Cancer With Electronic Patient-Reported Outcome Measures: Scoping Review
Background: Electronic patient-reported outcome measures (ePROMs) are essential to clinical practice and research. The growth of eHealth technologies has provided unprecedented opportunities to collect information systematically through ePROMs. Although they are widely used in scientific research, more evidence is needed to determine their use and implementation in daily clinical practice. For example, when diagnosed, patients with lung cancer are at an advanced stage of the disease. This entails tremendous burden because of high mortality and losses in the different dimensions of the human being. In this case, monitoring symptoms and other outcomes help improve the patient’s quality of life. Objective: ePROMs offered unprecedented opportunities to collect information systematically. Our goal was to demonstrate that ePROMs are more useful in controlling patient symptoms, lung cancer, and overall survival than their alternatives, such as nonelectronic PROMs. Methods: This exploratory review considered articles published between 2017 and 2022 identified through searches of PubMed, Scopus, Cochrane, CINAHL, and PsycINFO. We found 5097 articles; after removing the duplicates, we reduced them to 3315. After reading the summary, we were left with 56. Finally, after applying the exclusion criteria, we reviewed 12. The 5-step framework by Arksey and O’Malley was used to refine the initial search results with the following research questions: Do ePROMs help physician-patient communication? To what extent do they improve decision-making? Are institutions and their digitization policies barriers to or facilitators of this process? and What else is needed for routine implementation? Results: This review included 12 articles. We found that ePROMs are an integrative and facilitative communication tool, highlighting their importance in the relationship between palliative care and medical oncology. ePROMs help assess patient symptoms and functionality more accurately and facilitate clinical decision-making. In addition, it allows for more precise predictions of overall patient survival and the adverse effects of their treatments. The main institutional obstacles are the initial investment, which can be costly, and the data protection policy. However, enablers included better funding through the development of telemedicine, support from institutional leaders to overcome resistance to change, and transparent policies to ensure the safe and secure use of ePROMs. Conclusions: Routine collection of remote ePROMs is an effective and valuable strategy for providing real-time clinical feedback. In addition, it provides satisfaction to patients and professionals. Optimizing ePROMs in patients with lung cancer leads to a more accurate view of health outcomes and ensures quality patient follow-up. It also allows us to stratify patients based on their morbidity, creating specific follow-ups for their needs. However, data privacy and security are concerns when using ePROMs to ensure compliance with local entities. At least four barriers were identified: cost, complex programming within health systems, safety, and social and health literacy.
- Open Access
- 4 February 2023
- Published by JMIR Publications Inc. in JMIR Preprints
Improving the Understanding and Managing of the Quality of Life of Patients With Lung Cancer With Electronic Patient-Reported Outcome Measures: Scoping Review (Preprint)
BACKGROUND Electronic patient-reported outcome measures (ePROMs) are essential to clinical practice and research. The growth of eHealth technologies has provided unprecedented opportunities to collect information systematically through ePROMs. Although they are widely used in scientific research, more evidence is needed to determine their use and implementation in daily clinical practice. For example, when diagnosed, patients with lung cancer are at an advanced stage of the disease. This entails tremendous burden because of high mortality and losses in the different dimensions of the human being. In this case, monitoring symptoms and other outcomes help improve the patient’s quality of life. OBJECTIVE ePROMs offered unprecedented opportunities to collect information systematically. Our goal was to demonstrate that ePROMs are more useful in controlling patient symptoms, lung cancer, and overall survival than their alternatives, such as nonelectronic PROMs. METHODS This exploratory review considered articles published between 2017 and 2022 identified through searches of PubMed, Scopus, Cochrane, CINAHL, and PsycINFO. We found 5097 articles; after removing the duplicates, we reduced them to 3315. After reading the summary, we were left with 56. Finally, after applying the exclusion criteria, we reviewed 12. The 5-step framework by Arksey and O’Malley was used to refine the initial search results with the following research questions: Do ePROMs help physician-patient communication? To what extent do they improve decision-making? Are institutions and their digitization policies barriers to or facilitators of this process? and What else is needed for routine implementation? RESULTS This review included 12 articles. We found that ePROMs are an integrative and facilitative communication tool, highlighting their importance in the relationship between palliative care and medical oncology. ePROMs help assess patient symptoms and functionality more accurately and facilitate clinical decision-making. In addition, it allows for more precise predictions of overall patient survival and the adverse effects of their treatments. The main institutional obstacles are the initial investment, which can be costly, and the data protection policy. However, enablers included better funding through the development of telemedicine, support from institutional leaders to overcome resistance to change, and transparent policies to ensure the safe and secure use of ePROMs. CONCLUSIONS Routine collection of remote ePROMs is an effective and valuable strategy for providing real-time clinical feedback. In addition, it provides satisfaction to patients and professionals. Optimizing ePROMs in patients with lung cancer leads to a more accurate view of health outcomes and ensures quality patient follow-up. It also allows us to stratify patients based on their morbidity, creating specific follow-ups for their needs. However, data privacy and security are concerns when using ePROMs to ensure compliance with local entities. At least four barriers were identified: cost, complex programming within health systems, safety, and social and health literacy.
- 4 February 2023
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessImproving the Understanding and Managing of the Quality of Life of Patients With Lung Cancer With Electronic Patient-Reported Outcome Measures: Scoping Review (Preprint)
BACKGROUND Electronic patient-reported outcome measures (ePROMs) are essential to clinical practice and research. The growth of eHealth technologies has provided unprecedented opportunities to collect information systematically through ePROMs. Although they are widely used in scientific research, more evidence is needed to determine their use and implementation in daily clinical practice. For example, when diagnosed, patients with lung cancer are at an advanced stage of the disease. This entails tremendous burden because of high mortality and losses in the different dimensions of the human being. In this case, monitoring symptoms and other outcomes help improve the patient’s quality of life. OBJECTIVE ePROMs offered unprecedented opportunities to collect information systematically. Our goal was to demonstrate that ePROMs are more useful in controlling patient symptoms, lung cancer, and overall survival than their alternatives, such as nonelectronic PROMs. METHODS This exploratory review considered articles published between 2017 and 2022 identified through searches of PubMed, Scopus, Cochrane, CINAHL, and PsycINFO. We found 5097 articles; after removing the duplicates, we reduced them to 3315. After reading the summary, we were left with 56. Finally, after applying the exclusion criteria, we reviewed 12. The 5-step framework by Arksey and O’Malley was used to refine the initial search results with the following research questions: Do ePROMs help physician-patient communication? To what extent do they improve decision-making? Are institutions and their digitization policies barriers to or facilitators of this process? and What else is needed for routine implementation? RESULTS This review included 12 articles. We found that ePROMs are an integrative and facilitative communication tool, highlighting their importance in the relationship between palliative care and medical oncology. ePROMs help assess patient symptoms and functionality more accurately and facilitate clinical decision-making. In addition, it allows for more precise predictions of overall patient survival and the adverse effects of their treatments. The main institutional obstacles are the initial investment, which can be costly, and the data protection policy. However, enablers included better funding through the development of telemedicine, support from institutional leaders to overcome resistance to change, and transparent policies to ensure the safe and secure use of ePROMs. CONCLUSIONS Routine collection of remote ePROMs is an effective and valuable strategy for providing real-time clinical feedback. In addition, it provides satisfaction to patients and professionals. Optimizing ePROMs in patients with lung cancer leads to a more accurate view of health outcomes and ensures quality patient follow-up. It also allows us to stratify patients based on their morbidity, creating specific follow-ups for their needs. However, data privacy and security are concerns when using ePROMs to ensure compliance with local entities. At least four barriers were identified: cost, complex programming within health systems, safety, and social and health literacy.
- Open Access
- 1 June 2019
- Published by Associacao Portuguesa de Medicina Geral e Familiar in Revista Portuguesa de Clínica Geral
- Vol. 35 (3) , 197-202
Doença Celíaca, Gastrite Atrófica Autoimune e Helicobacter pylori na Anemia Refratária ao Ferro Oral
Doença Celíaca, Gastrite Atrófica Autoimune e Helicobacter pylori na Anemia Refratária ao Ferro Oral
- 1 June 2019
- Published by Associacao Portuguesa de Medicina Geral e Familiar in Revista Portuguesa de Clínica Geral
- Vol. 35 (3) , 197-202
Open AccessDoença Celíaca, Gastrite Atrófica Autoimune e Helicobacter pylori na Anemia Refratária ao Ferro Oral
Doença Celíaca, Gastrite Atrófica Autoimune e Helicobacter pylori na Anemia Refratária ao Ferro Oral